Ptc Therapeutics annual gross margin
2015
2016
2017
2018
2019
2022
2023
2024
2025
Ptc Therapeutics Gross Margin Growth & History (PTCT)
Ptc Therapeutics's gross margin was 97.28% for fiscal 2025.
View full Ptc Therapeutics company overviewPtc Therapeutics annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 97.28% | +4.40 pp |
| 2024 | 2024-12-31 | 92.89% | −0.13 pp |
| 2023 | 2023-12-31 | 93.02% | −0.59 pp |
| 2022 | 2022-12-31 | 93.61% | — |
| 2019 | 2019-12-31 | 96.05% | +0.83 pp |
| 2018 | 2018-12-31 | 95.21% | −2.43 pp |
| 2017 | 2017-12-31 | 97.65% | −2.35 pp |
| 2016 | 2016-12-31 | 100.00% | 0.00 pp |
| 2015 | 2015-12-31 | 100.00% | — |
Ptc Therapeutics quarterly gross margin
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 94.47% | +0.86 pp |
| Q1 2026 | 2026-03-31 | 89.72% | — |
| Q4 2025 | 2025-12-31 | 95.78% | — |
| Q3 2025 | 2025-09-30 | 92.52% | — |
| Q2 2025 | 2025-06-30 | 93.62% | — |
| Q4 2019 | 2019-12-31 | 96.33% | +0.12 pp |
| Q3 2019 | 2019-09-30 | 95.79% | +1.93 pp |
| Q2 2019 | 2019-06-30 | 96.25% | −0.01 pp |
| Q1 2019 | 2019-03-31 | 95.57% | +1.00 pp |
| Q4 2018 | 2018-12-31 | 96.21% | −35.07 pp |
| Q3 2018 | 2018-09-30 | 93.86% | −2.36 pp |
| Q2 2018 | 2018-06-30 | 96.26% | −2.16 pp |
| Q1 2018 | 2018-03-31 | 94.57% | −5.28 pp |
| Q4 2017 | 2017-12-31 | 131.28% | +30.99 pp |
| Q3 2017 | 2017-09-30 | 96.21% | −3.79 pp |
| Q2 2017 | 2017-06-30 | 98.42% | −1.58 pp |
| Q1 2017 | 2017-03-31 | 99.85% | −0.15 pp |
| Q4 2016 | 2016-12-31 | 100.29% | — |
| Q3 2016 | 2016-09-30 | 100.00% | — |
| Q2 2016 | 2016-06-30 | 100.00% | — |
| Q1 2016 | 2016-03-31 | 100.00% | — |
Ptc Therapeutics gross margin trends
Between the periods ended 2015-12-31 and 2025-12-31, Ptc Therapeutics's gross margin decreased from 100.00% to 97.28%, a change of −2.72 percentage points. The latest reported quarter, Q2 2026, shows 94.47%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Ptc Therapeutics source filings ↗Community posts
PTC raises its revenue forecast as Sephience sales expand
PTC Therapeutics ($PTCT) raised its full-year 2026 revenue expectation to $1.29–$1.32 billion and increased product-sales guidance to $960–$990 million from $850–$950 million. Third-quarter 2026 product and royalty revenue reached $357.6 mi ...
